BioLab at OICR is a shared instrumentation division that provides advanced state-of-the-art equipment, tools and technical know-how to support lab research activities for OICR researchers and collaborators.

The mission of BioLab is to educate, enable and inspire OICR researchers and collaborators to achieve their research objectives and professional development goals by providing instrument access, knowledge transfer and continued education on advanced cancer technologies and innovations.

BioLab provides its educational offerings through three main intersecting activities:

  • BioLab provides access to advanced technology and leading-edge instrumentation, tools and supports training that brings new knowledge and skills.
  • To maximize the exposure to current knowledge in transdisciplinary cancer research, BioLab offers participation in the networks of science communication such as online webinars and virtual events.
  • BioLab fosters educational collaboration between researchers and technology providers by sharing knowledge, resources and expertise for faster and more effective communication and learning.

BioLab Hub

To better assist OICR researchers during the COVID-19 pandemic, BioLab has extended its educational offerings by launching the BioLab Hub initiative.

BioLab Hub posts bi-weekly selections of free webinars and virtual events (symposiums, conferences, and summits) on new technologies, instrumentation, applications and innovations related to cancer research.

Upcoming Webinars and Virtual Events

What Is a Microarray?
On Demand

Abstract: A microarray is a miniaturized assay comprising a solid surface printed with a multitude of molecules which are available for multiplex interaction and detection. They have applications in many fields including genomics, proteomics, diagnostics, biomarker quantitation and others.

Exploring Biology Through a New Lens: A Spatial Approach
On Demand

Abstract: In this GEN webinar, our distinguished presenter Dr. Sizun Jiang will detail data from a clinical cohort of cutaneous T cell lymphoma (CTCL) patients, in which he and his laboratory show how to robustly titrate and validate antibodies with the highly multiplexing capabilities of CODEX®. Dr. Jiang will also describe how his findings can be extended to understanding immune-tumor interactions for a better understanding of immunotherapy responses and strategies in CTCL. Additionally, we will hear from Dr. Niro Ramachandran, who has had his finger on the pulse of the spatial biology market since its inception. He will discuss the need for new techniques that take full advantage of complementary technologies to unravel complex biological mechanisms in healthy and diseased tissues. Finally, he’ll provide an overview of Akoya’s Imaging Innovators (I2) network, a first-of-its-kind collaboration of pioneering scientists from world-class research organizations with ambitions to advance the field of spatial biology. Dr. Jiang is a founding member of the I2 network.

A New Streamlined Approach for Extracellular Vesicle Protein Characterization
On Demand

Abstract: Characterization of protein expression in extracellular vesicles (EVs) and exosomes following MISEV guidelines is a critical component of all EV studies but made difficult by the challenges of EV isolation and sensitive, reproducible protein measurement in EV samples.  In this webinar, we will present a new streamlined workflow for extracellular vesicle protein characterization made possible through a collaboration between ProteinSimple, a Bio-Techne brand, and QIAGEN.  This validated workflow enables simple and fast intact EV isolation using the exoEasy Maxi Kit from QIAGEN followed by sensitive, fully automated Western-based protein analysis of EV isolates using Simple Western from ProteinSimple.  Optimized protein assays showing EV and non-EV markers from multiple MISEV categories will be presented.

Overcoming Plasmid DNA Limitations in Advanced Therapy Manufacturing
On Demand

Abstract: In this GEN webinar, two distinguished presenters Dr. Tommy Duncan and Dr. Jill Makin, will address these industry challenges and discuss an alternative to plasmid DNA—a synthetic, antibiotic-free DNA vector called dbDNA™ (doggybone DNA). Additionally, we will learn how dbDNA can address the issues of traditional fermentation while achieving a significantly faster turnaround for GMP production and superior safety due to the elimination of bacterial sequences. With supportive case studies, this webinar will also explain how dbDNA is uniquely positioned to enable the rapid, global-scale DNA production that is so urgently required.

Key Factors to Accelerate Drug Discovery
On Demand

Abstract: Unique techniques and the speed of drug discovery are two critical factors for biomedical research and health care, which importantly includes cancer research and oncology, where the potential applications are vast. The development of rabbit monoclonal antibody technology provides an alternative source of monoclonal antibodies with higher specificity and less cost for the development of routine targeted therapy against cancers. In addition, integrated with the platform of kit development for drug safety monitoring, further accelerating the speed of drug discovery

Exosomes: From pure isolation to standardized analysis by flow cytometry
On Demand

Abstract From waste disposal to promising biomarkers and therapeutic agents, exosomes and other extracellular vesicles are valuable in research due to their role as intracellular messengers in health and disease. While their translational applications appear unlimited, the study of exosomes is challenged by their small size and heterogenous nature. In this webinar you will learn about the common methods for exosome research and the proficient tools that Miltenyi Biotec offers to isolate and analyze exosomes.

Improving T-cell Function in the Solid Tumor Microenvironment Using Advanced Immunotherapeutic Strategies
On Demand

Abstract: Learn about how IsoPlexis single cell innovative technology enables researchers to fine-tune their immunotherapeutic candidates and identify what differentiates immune cell potency, cell product toxicity, and functional differences between patient responders and non-responders to immunotherapies.

Ensure Reproducibility in Your B Cell Analysis
On Demand

Abstract: The primary role of B cells is to secrete antibodies, boosting our adaptive immune responses, making them an essential part of our immune system. With such an imperative function, they are of great research interest in basic to clinical studies. B cells also play a crucial role in antibody-based drug development. However, their complex forms and subsets can lead to difficult analysis.

OICR Events